Page 33 - Read Online

Ballestri et al. Metab Target Organ Damage 2023;3:1 https://dx.doi.org/10.20517/mtod.2022.23 Page 21 of 22

non-alcoholic fatty liver disease patients: a systematic review & meta-analysis. PLoS One 2015;10:e0127782. DOI
83. Cassinotto C, Boursier J, de Lédinghen V, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear
imaging, FibroScan, and ARFI with liver biopsy. Hepatology 2016;63:1817-27. DOI PubMed
84. Jiang W, Huang S, Teng H, et al. Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic
fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis. BMJ Open 2018;8:e021787. DOI PubMed PMC
85. Herrmann E, de Lédinghen V, Cassinotto C, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave
elastography: an individual patient data-based meta-analysis. Hepatology 2018;67:260-72. DOI PubMed PMC
86. Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease.
Gastroenterology 2019;156:1264-1281.e4. DOI PubMed PMC
87. Selvaraj EA, Mózes FE, Jayaswal ANA, et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with
NAFLD: a systematic review and meta-analysis. J Hepatol 2021;75:770-85. DOI PubMed
88. Petta S, Sebastiani G, Bugianesi E, et al. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty
liver disease cirrhosis. J Hepatol 2018;69:878-85. DOI PubMed
89. Berzigotti A, Ferraioli G, Bota S, Gilja OH, Dietrich CF. Novel ultrasound-based methods to assess liver disease: the game has just
begun. Dig Liver Dis 2018;50:107-12. DOI PubMed
90. Park CC, Nguyen P, Hernandez C, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and
noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology
2017;152:598-607.e2. DOI PubMed PMC
91. Lee YS, Lee JE, Yi HS, et al. MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic
fatty liver disease. Hepatol Int 2022;16:316-24. DOI PubMed
92. Polyzos SA, Kechagias S, Tsochatzis EA. Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations
and treatment considerations. Aliment Pharmacol Ther 2021;54:1013-25. DOI PubMed
93. Veracruz N, Hameed B, Saab S, Wong RJ. The association between nonalcoholic fatty liver disease and risk of cardiovascular
disease, stroke, and extrahepatic cancers. J Clin Exp Hepatol 2021;11:45-81. DOI PubMed PMC
94. Friedrich-Rust M, Schoelzel F, Maier S, et al. Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease:
a single-blinded prospective mono-center study. PLoS One 2017;12:e0186720. DOI PubMed PMC
95. Song Y, Dang Y, Wang P, Tian G, Ruan L. CHD is associated with higher grades of NAFLD predicted by liver stiffness. J Clin
Gastroenterol 2020;54:271-7. DOI PubMed PMC
96. Lombardi R, Airaghi L, Targher G, et al. Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters
associates with macrovascular and microvascular complications in patients with type 2 diabetes. Liver Int 2020;40:347-54. DOI
PubMed
97. Mantovani A, Turino T, Lando MG, et al. Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its
association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes. Diabetes Metab
2020;46:296-303. DOI PubMed
98. Mikolasevic I, Rahelic D, Turk-Wensween T, et al. Significant liver fibrosis, as assessed by fibroscan, is independently associated
with chronic vascular complications of type 2 diabetes: a multicenter study. Diabetes Res Clin Pract 2021;177:108884. DOI
PubMed
99. Long MT, Zhang X, Xu H, et al. Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: the framingham heart
study. Hepatology 2021;73:548-59. DOI PubMed PMC
100. Pennisi G, Di Marco V, Buscemi C, et al. Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an
asymptomatic general population. J Gastroenterol Hepatol 2021;36:2389-96. DOI PubMed
101. Park JG, Jung J, Verma KK, et al. Liver stiffness by magnetic resonance elastography is associated with increased risk of
cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2021;53:1030-7.
102. Ciardullo S, Cannistraci R, Mazzetti S, Mortara A, Perseghin G. Nonalcoholic fatty liver disease, liver fibrosis and cardiovascular
disease in the adult US population. Front Endocrinol 2021;12:711484. DOI PubMed PMC
103. Liu K, Wong VW, Lau K, et al. Prognostic value of controlled attenuation parameter by transient elastography. Am J Gastroenterol
2017;112:1812-23. DOI PubMed
104. Shili-Masmoudi S, Wong GL, Hiriart JB, et al. Liver stiffness measurement predicts long-term survival and complications in non-
alcoholic fatty liver disease. Liver Int 2020;40:581-9. DOI PubMed
105. Mikolasevic I, Domislovic V, Ruzic A, et al. Elastographic parameters of liver steatosis and fibrosis predict independently the risk of
incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus. J Diabetes Complicat
2022;36:108226. DOI PubMed
106. Cardoso CRL, Villela-Nogueira CA, Leite NC, Salles GF. Prognostic impact of liver fibrosis and steatosis by transient elastography
for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro
Cohort study. Cardiovasc Diabetol 2021;20:193. DOI PubMed PMC
107. Grgurevic I, Salkic N, Mustapic S, et al. Liver and nonliver-related outcomes at 2 years are not influenced by the results of the fib-4
test and liver elastography in a real-life cohort of patients with type 2 diabetes. Can J Gastroenterol Hepatol 2021;2021:5582813.
DOI PubMed PMC
108. Petta S, Sebastiani G, Viganò M, et al. Monitoring occurrence of liver-related events and survival by transient elastography in